Researchers have identified two distinct stem cell–like populations from which relapse can arise in AML patients, which may help clinicians identify who will and won't respond to standard chemotherapy.
The 70-gene test could aid clinicians and patients in determining the optimal treatment course for breast cancer patients with a very low risk of death from the disease.
Using sticky nanoparticles, researchers have discovered a strategy to improve the immune system's detection of cancer proteins in order to optimize the effectiveness of immunotherapy.
Researchers have discovered a way to test for multiple neuroblastoma-associated genes simultaneously, which may help to improve definition of disease status in patients with relapsed/refractory neuroblastoma.
Men with prostate cancer and one additional primary cancer may harbor a mutation in a cancer-predisposing gene, but the majority of these men do not meet criteria for clinical genetic testing.
Neural stem cell therapy combined with a common cold virus may be a highly effective way of improving outcomes in patients with newly diagnosed malignant gliomas.
By better understanding the similarities and differences between T-cell receptors, researchers will be better able to develop personalized cancer immunotherapies.
